Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 
Saturday, November 28, 2009, 3:31PM ET - U.S. Markets Closed. Dow Down 1.48% Nasdaq Down 1.73%
Progenics Pharmaceuticals Inc. (PGNX)On Nov 27: 3.93  Down 0.14 (3.44%)  
MORE ON PGNX
Quotes
Charts
News & Info
Company
Analyst Coverage
HereResearch Reports
Ownership
Financials

Research ReportsGet Research Reports for:
RECENT REPORTS
ReleasedContributorAuthorTitlePagesPrice
29-Nov-2009PriceTarget Research, Inc. N/A PGNX has a current Overall Rating of D (Negative).7 $25
26-Nov-2009ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS18 $49
26-Nov-2009New Constructs, LLC N/A PGNX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19 $10
26-Nov-2009Pechala's ReportsLubomir PechalaPROGENICS PHARMACEUTICALS INC (PGNX=US) - REPORT FOR ACTIVE TRADERS4 $25
24-Nov-2009Zacks Investment Research Inc. N/A PROGENICS PHARM (PGNX) Zacks Company Snapshot1 $10
23-Nov-2009PriceTarget Research, Inc. N/A Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 18 new Laggards.58 $20
23-Nov-2009Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71 $199
23-Nov-2009Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569 $299
23-Nov-2009ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for PGNX13 $25
23-Nov-2009Market Edge N/A Market Edge Equity Research Report4 $10
View All Reports for PGNX ...

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Research Reports for Another Symbol: Symbol Lookup
•Upgrades & Downgrades•Conference Calls